AKEAU UNNAHALEKHAKA
Thailand
Akeau Unnahalekhaka (Thailand)
Professor Dr. Akeau Unahalekhaka
RN, Ph.D. (Epidemiology)
Professor Akeau Unahalekhaka graduated Bachelor of Science in Nursing, Master of Science and Ph.D. in Epidemiology. She also received Certificate in Surveillance and Applied Epidemiology for HIV and AIDS from Centers for Disease Control and Prevention (CDC), USA and Certificate in Statistical, Epidemiological and Operational Methods Applied in Medicine and Public Health from University of Brussels, Belgium. She worked Division of Epidemiology, Ministry of Public Health, Thailand as a Disease Control Officer, Chief of Planning and Evaluation Section for 14 years. She became professor at Faculty of Nursing, Chiang Mai University since 1992. She was a guest speaker and consultant in IPC throughout Thailand since 1988. She used to be an Executive Board member of the International Federation of Infection Control (IFIC), Infection Control Corresponding Reference Group of the Joanna Briggs Institute, Guideline Development Group of the World Health Organization.
She is currently a consultant of Central Sterilizing Services Association of Thailand, Council member of the Asia Pacific Society of Infection Control (APSIC), The Patient Safety Goals Committee, Hospital Accreditation and the National Patient and Personnel Safety Committee of Ministry of Public Health, Thailand.
She wrote many books on IPC since 1995 (e.g., Surveillance and Outbreak Investigation of Nosocomial Infections, Epidemiology and Prevention of Hospital-associated infection, Disinfection and Sterilization, Prevention of Multidrug- Resistant Organisms Transmission in Hospitals, Prevention of Ventilator-Associated Pneumonia & etc.)
She currently works at Faculty of Nursing, Chiang Mai University, Chiang Mai Thailand as a Professor.
AMBER MARIE VASQUEZ
United States of America
Amber Marie Vasquez (United States of America)
Amber Vasquez, MD, MPH is a physician of Internal Medicine and Infectious Diseases. She is currently a medical officer in the International Infection Control Program in the Division of Healthcare Quality Promotion at the U.S. Centers for Disease Control and Prevention in Atlanta. She joined CDC in 2015 as an Epidemic Intelligence Service officer, preventing and responding to disease outbreaks in U.S. healthcare settings. Since 2017 she has served as the implementation lead for the International Infection Control Program’s activities in Southeast Asia, primarily supporting infection prevention and control, healthcare-associated infection surveillance, antimicrobial resistance surveillance, and quality improvement activities in Vietnam and Thailand. During her time at CDC, Dr. Vasquez has also played a leading role responding to outbreaks in acute and long-term care hospitals and outpatient healthcare settings, including outbreaks of healthcare-associated infections, rare fungal infections, novel drug-resistant bacteria, Zika virus, Ebola virus, and COVID-19.
ANDREAS VOSS
Netherlands
Andreas Voss (Netherlands)
Andreas Voss, MD, PhD
Andreas Voss is professor and chair of the Department of Clinical-Microbiology and Infection Control at the University Medical Center of Groningen, The Netherlands. His expertise is in the field of infection prevention and control, in particular the epidemiology of antimicrobial resistance, hand hygiene and behavior change.
Presently, he is president of the International Society of Antimicrobial Chemotherapy (ISAC) and board member of the Dutch Society for Medical Microbiology, as well as a past member of the Executive of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the Society for Healthcare Epidemiology of America (SHEA), and the Infection Control African Network (ICAN).
Andreas Voss was the co-founder of the International Conference on Infection Control and Prevention (ICPIC) and Founding Editor of the BMC journal Antimicrobial Resistance and Infection Control (www.ARICjournal.com). He has >350 peer-reviewed journal publications to his name (H-index overall: 71, Google Scholar profile http://scholar.google.com/citations?hl=en&user=RPiLnxoAAAAJ&view_op=list_works)
ANDREW STEWARDSON
Australia
Andrew Stewardson (Australia)
Andrew is an Infectious Diseases physician and Associate Professor at the Department of Infectious Diseases, Alfred Health and Monash University (Melbourne, Australia). He has a PhD (University of Melbourne), a Master of Science in Epidemiology (Harvard School of Public Health), and a Diploma of Advanced Studies in Clinical Research (University of Geneva). His research has focused on the health and economic impact of antimicrobial resistance and healthcare-associated infections, the transmission dynamics of antimicrobial resistance, and the implementation of infection prevention and control interventions. He spent four years as a research fellow with the Infection Control Program and WHO Collaborating Centre on Patient Safety at the University of Geneva Hospitals (Geneva, Switzerland). During this time, he was an external consultant for the WHO Patient Safety program. He has previously worked as National Project Manager at Hand Hygiene Australia. He’s a member of several Victorian and national healthcare infection and patient safety committees and is current Chair of the Australasian Society for Infectious Diseases (ASID) Healthcare Infection Control Special Interest Group (HICSIG).
ANUCHA APISARNTHANARAK
Thailand
Anucha Apisarnthanarak (Thailand)
Dr. Anucha Apisarnthanarak is current the Professor and Chief of Infectious Diseases Division at Thammasat University Hospital. He also serves as an Adjunct Visiting Professor at Division of Infectious Diseases, Washington University School of Medicine, USA. Dr. Apisarnthanarak’s research focus included infection prevention in resource-limited setting, infection control to prevent multi-drug resistant microorganisms as well as outbreak investigations. He published more than 250 peer-review articles and more than 20 peer-review book chapters. He has been a key committee member of many national and international societies including Thai National Nosocomial Infection Group, Society of Healthcare Epidemiology of America, and Asia Pacific Society of Infection Control. Dr. Apisarnthanarak also serves as editorial board for key infectious diseases and infection control journals including Clinical Infectious Diseases, Infection Control and Hospital Epidemiology and American Journal of Infection Control.
BENEDETTA ALLEGRANZI
Switzerland
Dr. Benedetta Allegranzi (Switzerland)
Professor Benedetta Allegranzi
WHO Infection Prevention and Control (IPC) Hub, Integrated Health Services Department, Universal Health Coverage/Life Course Division, World Health Organization Headquarters, Geneva, Switzerland
Benedetta Allegranzi is an infectious diseases specialist, with Diplomas in Tropical Medicine and Hygiene (University of Liverpool, UK) and Clinical Research (University of Geneva, Switzerland). From 1994 to 2006, she worked as infectious diseases and infection prevention and control (IPC) specialist and assistant professor at the University of Verona, Italy, as well as in Burundi, Malaysia and some other countries.
She now works at the World Health Organization (WHO) HQ since 2006, as the technical lead of the IPC Hub and the IPC Taskforce and co-lead of the IPC pillar of the WHO response to the COVID-19 pandemic.
Benedetta Allegranzi is also Adjoint Professor at the Global Health Institute and at the Infection Control Programme, Faculty of Medicine, University of Geneva.
With her team, she has provided technical support to many countries in all continents and has led research in the field of health care associated infections, antimicrobial resistance, and IPC; she has been responsible for the development of many new global IPC guidelines and implementation strategies and tools, and two global campaigns on injection safety and hand hygiene (in 182 countries).
She is leading or senior author of 65 WHO official publications, and author or co-author of over 200 scientific publications, and more than 20 book chapters.
Contact: allegranzib@who.int
BRENDA ANG SZE PENG
Singapore
Brenda Ang Sze Peng (Singapore)
Brenda Sze Peng Ang
Senior Consultant, Department of Infectious Diseases, National Centre for Infectious Diseases
Tan Tock Seng Hospital and Director of Infection Prevention and Control.
Brenda holds faculty appointments in both the Yong Loo Lin and Lee Kong Chian Schools of Medicine (NUS and NTU respectively) as well as visiting consultant status to Singapore General Hospital and Sengkang General Hospital. She is a member of the Chapter of Infectious Disease Physicians, Academy of Medicine, Singapore, and was Chairman of the Specialist Training committee for 2 terms.
As Chairman of the Infection Control Committee, she has led infection prevention and control efforts on the campus for more than 25 years, including overcoming emerging infectious disease outbreaks, from Nipah in 1999, SARS in 2003, H1N1 in 2009, to COVID from 2020. She is also the Chairman of the Infection Control Committee of the National Healthcare Group, and a member of the National Infection Prevention and Control Committee of the Ministry of Health. Her work and research interests are in epidemiology of multi drug-resistant organisms and outbreak preparedness and response.
CHAN SI MIN
Singapore
Chan Si Min (Singapore)
Dr Chan is the Head and Senior Consultant in the Division of Paediatric Infectious Diseases, Khoo Teck Puat-National University Children’s Medical Institute, National University Hospital, Singapore. She trained as a Paediatric specialist in London and has a Postgraduate Diploma in Paediatric Infectious Diseases from the University of Oxford. Her clinical practice includes all areas of Paediatric Infectious Diseases. She sits on multiple hospital and national committees for antimicrobial stewardship, infection prevention, immunisation, and national outbreak response and management for children.
DALE FISHER
Singapore
Dale Fisher (Singapore)
Professor Dale Fisher is an Australian infectious diseases physician who first moved to the National University Hospital, Singapore in March 2003 during the SARS outbreak. He chaired NUH’s IPC committee from 2006 until recently overseeing formative change in its systems. He was also instated as the inaugural chair of Singapore’s National IPC committee in 2014 and is the Group chief of Medicine at National University Health Systems. At the international level he chairs the steering committee of WHO’s Global Outbreak Alert & Response Network (GOARN), has supported many WHO IPC guideline efforts and was one of 12 international technical experts who visited China in February 2020 to investigate the COVID-19 outbreak. Other outbreak response contributions include deployments across Asia for national influenza outbreaks and to West Africa in 2014 and 2015 for the Ebola response. He has conducted many IPC trainings in Asia, has authored over 200 peer-reviewed publications and given almost 150 invited and plenary presentations at international conferences. Many awards for his work in IPC include a national clinical excellence award in 2013, in 2018 the Minister for Health Award and last year Singapore’s National Outstanding Clinician Award.
DAVID LYE
Singapore
David Lye (Singapore)
Associate Professor David LYE Chien Boon (MBBS, FRACP, FAMS, FRCP) graduated in medicine on the Dean’s List from the University of Melbourne in 1996 and completed specialty training in infectious diseases in Australia in 2004. He returned to Singapore to work at the Department of Infectious Diseases, Tan Tock Seng Hospital (TTSH) in 2005.
He is currently senior consultant, Department of Infectious Diseases, TTSH and associate professor at Yong Loo Lin School of Medicine, National University of Singapore as well as Lee Kong Chian School of Medicine, Nanyang Technological University. At the National Centre for Infectious Diseases, Professor Lye is Director of the Infectious Disease Research and Training Office and leads the Singapore Infectious Disease Clinical Research Network (SCRN) as well as the Training and Education Office. At TTSH, he founded and led the Antimicrobial Stewardship Programme from 2009 to 2018. He is the current chair of the National Antimicrobial Stewardship Expert Panel. He is a member of National Antimicrobial Resistance Control Committee and One Health Antimicrobial Resistance Project Team, Ministry of Health, Singapore.
Professor Lye has held more than SGD$10million in research grant as principal investigator to date. He has published more than 220 peer-reviewed manuscripts in journals such as NEJM, Lancet, JAMA, Lancet Infectious Diseases, Lancet Global Health as well as Science, Science Translational Medicine, Nature Biotechnology and Nature Communications.
He is an associate editor, BMC Infectious Diseases and Scientific Reports; a member of the editorial board, JAC-Antimicrobial Resistance; and a member of the Editorial Advisory Board, Journal Global Antimicrobial Resistance.
Professor Lye is President of the College of Physicians, Singapore and Society of Infectious Disease (Singapore). He is an advocate for HIV prevention as Vice President of Action for AIDS. Internationally, he is on the executive committee of Asia Pacific Society of Clinical Microbiology and Infection, and International Society of Antimicrobial Chemotherapy, and council of International Society of Infectious Diseases.
Professor Lye’s awards include: Dean’s Award for Teaching Excellence, Yong Loo Lin School of Medicine, National University of Singapore, 2016; National Healthcare Group Team Recognition Award 2017, Silver, Hospital Acquired Infection Elimination Collaborative; and Tan Tock Seng Hospital Milestone Award 2017, Antimicrobial Stewardship Programme.
DAVID WEBER
United States of America
David Weber (United States of America)
Dr. David Jay Weber has been on the faculty of the University of North Carolina at Chapel Hill since 1985 where he is currently the Charles Addison and Elizabeth Ann Sanders Distinguished Professor of Medicine, Pediatrics and Epidemiology in the UNC School of Medicine, and UNC Gillings School of Global Public Health. Dr. Weber received his Bachelors of Arts (B.A.) degree from Wesleyan University in 1973, his Medical Degree (M.D.) from the University of California, San Diego in 1977, a Master’s in Public Health (M.P.H.) from Harvard University in 1985 and completed his medicine residency and infectious disease fellowship at the Massachusetts General Hospital in 1985. He is Board Certified in Internal Medicine, Infectious Disease, Critical Care Medicine, and Preventive Medicine. Dr. Weber serves as an Associate Chief Medical Officer and Medical Director of Infection Prevention for the UNC Medical Center. He serves as Medical Director of the NC Program in Infection Control and Epidemiology (SPICE). He is the Secretary of the Board of the Society for Healthcare Epidemiology of America and an Associate Editor of Infection Control & Hospital Epidemiology. Dr. Weber has published more than 450 scientific papers in the peer-reviewed literature and more than 600 total papers and chapters. His research interests include the epidemiology of healthcare-associated infections, disinfection and sterilization, new and emerging infectious diseases (novel influenza, SARS-coV-2, MERS-coV, Ebola, Candida auris), response to biothreats, nontuberculous mycobacteria, control of drug resistant pathogens, immunization practices (especially of healthcare personnel), zoonotic diseases, and epidemiology of tuberculosis.
DIDIER PITTET
Switzerland
Didier Pittet (Switzerland)
Professor DIDIER PITTET, MD, MS, CBE
Professor Didier Pittet is the Hospital Epidemiologist and Director of the Infection Control Programme & World Health Organization (WHO) Collaborating Centre on Patient Safety, University of Geneva Hospitals and Faculty of Medicine, Switzerland. He holds Honorary Professorships at Imperial College (London), Hong Kong Polytechnic University School of Health Science (Hong Kong) and the First Medical School of the Fu (Shanghai). Professor Pittet is also a fellow of the Royal Medical Association (Ireland) and Honorary Member of the All-Russian Scientific Societies of Epidemiologists, Microbiologists and Parasitologists and the French Academy of Surgery.
Author and co-author of more than 500 publications in scientific journals and editor of the first textbook “Hand Hygiene – A Handbook for Medical Professionals” (Pittet, Boyce, Allegranzi, edition Wiley-Blackwell, 2017), Professor Pittet is a member of the editorial boards of many prestigious scientific journals, including The Lancet Infectious Diseases. He is also an editorial consultant for The Lancet. The books “Clean Hands Save Lives” (Editions L’Âge d’Homme, 2014), available in 19 languages and “Adapt to Adopt” (Editions Nouvelle Imprimerie Laballery, 2021) written by French writer Thierry Crouzet, and the documentary film “Clean Hands” (Aftermedia 2016, 8 languages) describe Didier Pittet’s medical odyssey dedicated to the promotion of hand hygiene worldwide.
Professor Pittet is the recipient of several national and international honors including a CBE (Commander of the British Empire) awarded by Her Majesty Queen Elisabeth II for services to the prevention of healthcare-associated infection in the UK (2007), the Society for Healthcare Epidemiology of America Lectureship (2008), the European Society of Clinical Microbiology and Infectious Diseases’ Award for Excellence (2009), the American Society for Microbiology (2016), the Robert Koch Award (2017) and the Pasteur Medal (2020).
Since 2005, Professor Pittet has been working closely with the WHO as the lead adviser of the First Global Patient Safety Challenge, whose Clean Care is Safer Care program is active in hospitals in 189 of the 195 UN member states. Professor Pittet conducts numerous research projects, in particular concerning the epidemiology, prevention and control of infections and the development of innovative strategies to improve hand hygiene compliance and the quality of patient care to promote their safety. He is also involved in numerous humanitarian projects. Professor Pittet is also credited with revolutionizing patient care processes in hospitals by replacing hand washing with soap and water with the systematic use of alcohol-based handrubs (ABHR) and spreading this change in practice to healthcare centers around the world. His work has also involved the donation of a patent-free ABHR solution formulation to the WHO to facilitate its global distribution at lower cost, leading to its inclusion in the WHO list of Essential Medicines in 2012.
In June 2020, Professor Pittet was appointed by the President of the French Republic, Mr. Emmanuel Macron, as president of an independent mission created to assess the management of the COVID-19 crisis and to better address the risks posed by the pandemic and delivered the report of this commission in May 2021. The mission’s primary objective was to assess the relevance, speed and proportionality of the French response in the management of the health, social and economic crises, in particular in comparison to other countries’ responses.
DOO RYEON CHUNG
South Korea
Doo Ryeon Chung (South Korea)
Professor of Medicine, Division of Infectious Diseases
Samsung Medical Center, Sungkyunkwan University School of Medicine
Chief, Division of Infectious Diseases, Samsung Medical Center
Director, Center of Infection Prevention and Control, Samsung Medical Center
Secretary General, Asia Pacific Foundation for Infectious Diseases (APFID)
Seoul, South Korea
Prof. Doo Ryeon Chung is the chief of Division of Infectious Diseases and the director of Center for Infection Prevention and Control, Samsung Medical Center. He is also the Secretary General of the Asia Pacific Foundation for Infectious Diseases (APFID) and the Asian Network for Surveillance of Resistant Pathogens (ANSORP).
Prof. Chung obtained his MD in 1991 and PhD later at the College of Medicine, Seoul National University. He completed clinical fellowship training in infectious diseases at Asan Medical Center, Seoul from 1997 to 1998, and research fellowship training at Channing Laboratory, Harvard Medical School in Boston from 1999 to 2002. Following an academic appointment to the Hallym University Sacred Heart Hospital from 2002 to 2006, he has been affiliated with Samsung Medical Center and Sungkyunkwan University School of Medicine since 2007. He had been the director of the Infection Prevention and Control Team at the Samsung Medical Center (SMC) from Sep. 2007 to Mar. 2015. He has served as the chief of the division of Infectious Diseases at SMC since Apr. 2015. He also has been the director of the Center for Infection Prevention and Control at SMC since Jan. 2016 and the chair of the Antimicrobial Stewardship Committee at the SMC since Mar. 2017.
Prof. Chung has been the Project Lead of the ANSORP since 2007 and the Secretary General of the APFID since Dec. 2015. He has also been working as an active member of a wide range of Korean and international academic societies. His main research topics include antimicrobial resistance of major human pathogens including Staphylococcus aureus, Streptococcus pneumoniae and Enterococcus; pneumonia; epidemiology and pathogenesis of invasive K. pneumoniae strains; prevention of healthcare-associated infections. He has authored more than 200 original papers in peer-reviewed international journals.
ERMIRA TARTARI
Malta
Ermira Tartari (Malta)
Dr Ermira Tartari
University of Malta, Malta
Dr. Ermira Tartari is a Lecturer and Researcher of Infection Prevention and Control at the Faculty of Health Sciences, University of Malta, Malta. She holds a PhD in Global Health from the University of Geneva. She is an IPC consultant in the Infection Prevention and Control Hub and Task Force at the WHO headquarter, Geneva, Switzerland. Ermira is a member of the European Committee on Infection Control (EUCIC) advisory board. She is passionate about all aspects of evidence-based infection prevention to advance the science in IPC and ultimately ensure patient safety and quality of healthcare services.
FONG SIEW MOY
Malaysia
Fong Siew Moy (Malaysia)
Dr Fong Siew Moy
- Graduated in 1990: MBBS in University Malaya, Kuala Lumpur
- 1995: MRCP (U.K.)
- 2001: Fellowship in Paediatrics Infectious Disease (Sydney, Australia)
- Feb 2020: FRCPCH (U.K)
Presently:
- Head of Department of Paediatrics in Sabah Women and Children’s Hospital and Sabah state Pediatrician since 1st March 2016
- Sabah State Infection Control and Antibiotic Committee Coordinator since 2002
- Central Committee Member in the National Infection Control Central Committee since 2008
- President of PKIAKK (Persatuan Kawalan Infeksi dan Antimikrobial Kota Kinabalu) since 2011
- President of Sabah Paediatric Association since 2016
- Past-President of KASIH (Kinabalu AIDS support services association (2004-2009)
Published papers in peer reviewed journal in the field of Paediatric HIV, Paediatric Melioidosis, Bronchopmeumonia and Neonatal Tetanus
GLENYS HARRINGTON
Australia
Glenys Harrington (Australia)
Glenys is an experienced Infection Control Consultant with an extensive background in managing and developing healthcare organization infection control programs in developed and developing countries. Glenys has post graduate qualifications in
Critical Care, Midwifery and Infectious Diseases. She has published widely and has specific interests in quality improvement initiatives to improve and sustain best practice to reduce healthcare associated infections, surveillance and the use of Statistical Process Control (SPC) charts, infection control during construction and renovation in healthcare settings, evidence based cleaning and disinfection strategies to reduce transmission of multi-resistant organisms (MROs) along with
infection control programs in community health and residential aged care settings. Glenys started her Infection Control career with the Infection Control and Hospital Epidemiology Unit at Alfred Health where she held the Infection Control Program Coordinator position with responsibility for Alfred, Caulfield and Sandringham hospitals providing tertiary referral acute, rehabilitation, residential aged care,
community health and state wide service for burns, heart and heart lung transplantation and trauma. In 2010 she established her own business called Infection Control Consultancy (ICC).
Glenys’ experience includes a World Health Organization (WHO) Consultancy to a SARS Outbreak Team, infection control program reviews, and tutorial attachments along with being an Honorary Advisor on the Hong Kong Infection Control Nurses Association (HKICNA) Research Review Panel. Glenys is currently an executive Committee member of the Asia Pacific Society of Infection Control (APSIC).
HELEN OH
Singapore
Helen Oh (Singapore)
Dr Helen Oh is a senior consultant with the Department of Infectious Diseases at Changi General Hospital (CGH). She received her medical degree from the National University of Singapore. She then went on to receive training in adult Infectious Disease from the University of British Columbia, Canada, as well as in molecular diagnostics from the University of Alabama, Birmingham, USA.
Dr Oh is a member of the Technical Advisory Group (TAG) on immunization and vaccine preventable diseases, Western Pacific Regional Office, World Health Organisation since 2011. Her research interests include dengue immunology, nosocomial infections, travel vaccines as well as environmental decontamination.
KALISVAR MARIMUTHU
Singapore
Kalisvar Marimuthu (Singapore)
Dr Kalisvar Marimuthu completed his advanced speciality training in Internal Medicine and Infectious Diseases in Singapore in 2010 and 2013 respectively. Subsequently, Dr Marimuthu trained in infection prevention and control as a Senior Research Fellow in the Infection Prevention and Control Unit of Geneva University Hospital under the guidance of Prof Stephan Harbarth and Prof Didier Pittet.
Dr Marimuthu is currently a senior consultant in Infectious Diseases at the National Centre for Infectious Diseases and Tan Tock Seng Hospital, Singapore. He is a member of the National Infection Prevention and Control Committee (NIPC) of Singapore and is also a consultant in the technical advisory committee for the World Health Organisation (WHO)’s carbapenem-resistant Enterobacteriaceae (CRE) guideline.
Dr Marimuthu’s primary research interest is in infection prevention and control, specifically in the application of next-generation sequencing for control of multidrug-resistant Gram-negative organisms.
KEITA MORIKANE
Japan
Keita Morikane (Japan)
Dr. Keita Morikane is a Chief and Professor of Division of Clinical Laboratory and Infection Control, Yamagata University Hospital, Yamagata, Japan. He is a Board Certified Surgeon, a certified Infection Control Doctor and certified physician of Clinical Laboratory Medicine. He is serving as Executive board member at Japan Society for Surgical Infection, Japanese Society for Infection Prevention and Control and Japanese Society of Laboratory Medicine. He graduated from University of Tokyo, pursued his surgical career as a GI surgeon until 2003, when he moved to National Institute of Infectious Diseases. After five years of experience in public health and healthcare-associated infection, he moved to his current affiliation. His research interest includes control of transmission of multidrug-resistant organisms, particularly by environmental infection control.
KOH TSE TSIEN
Singapore
Koh Tse Hsien (Singapore)
Dr Koh’s undergraduate medical training was at the University of Aberdeen in Scotland. He completed his specialist microbiology training at the Singapore General Hospital and the Royal London Hospital. In 2006, he did a research fellowship at the Toho University Medical School in Tokyo to study the characterization of beta-lactamases. In 2008 he did an attachment at Leiden University Medical Centre to study the molecular epidemiology of Acinetobacter spp. His research interests are in the molecular epidemiology of bacterial pathogens and resistance determinants of multidrug resistant bacteria.
LEE LAI CHEE
Singapore
Lee Lai Chee (Singapore)
Lee Lai Chee
Holding the position as Infection Prevention Lead in Singapore General Hospital
Publications and projects with key interests in training, care bundles, outbreak investigation and environmental hygiene
LOUIS CHAI
Singapore
Louis Chai (Singapore)
Dr. Louis Chai is Senior Consultant Infectious Diseases Physician and Associate Professor in the University Medicine Cluster, National University Health System, Singapore, as well as Principal Investigator, Opportunistic Infections Group, Division of Infectious Diseases, NUHS. Dr Chai’s interests lie in opportunistic and atypical infections in immunocompromised hosts, patients with altered immunity and host-pathogen interaction. These are also the themes of his research group. He remains deeply entrenched at the bedside in providing clinical service for general infectious diseases and internal medicine. Dr Chai is funded by the National Medical Research Council of Singapore and the National University Health System.
MOI LIN LING
Singapore
Moi Lin Ling (Singapore)
Dr Ling is the Director of Infection Control at Singapore General Hospital. A clinical microbiologist by training, Dr Ling has been active in Infection Control work in Singapore and the region. She has been conducting training programs in infection control in China, South East Asia as well locally in Singapore since 1995.
She is also the Adjunct Assistant Professor at the Duke-NUS Graduate Medical School, where she contributed to the training in microbiology. Her other interests are in quality improvement and research in antimicrobial resistance.
PO-REN HSUEH
Taiwan
Po-Ren Hsueh (Taiwan)
Po-Ren Hsueh, MD
Vice Dean and Professor, School of Medicine, China Medical University (CMU), Taiwan
Program Chairman, The Ph.D. Program for Aging, School of Medicine, CMU, Taiwan
Vice superintendent, Center of Laboratory Medicine, China Medical University Hospital (CMUH), Taichung, Taiwan
Director, Department of Laboratory Medicine, CMUH, Taichung, Taiwan
Visiting staff, Division of Infectious Diseases, Department of Internal Medicine, CMUH
Adjunct Professor, Departments of Laboratory Medicine and Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taiwan
Taiwan Country Ambassador, American Society of Microbiology
Professor Hsueh graduated from the National Taiwan University College of Medicine (NTUCM). He has completed several years of clinical internship and residency at the National Taiwan University Hospital (NTUH) and has been working at NTUH and NTUCM since 1995. Professor Hsueh moved to CMUH at CMU in 2021. Throughout his career, he has held president positions in several local and international societies, including the International Society of Antimicrobial Chemotherapy (ISAC), Asia-Pacific Society of Clinical Microbiology and Infection (APSCMI), Global Chinese Association of Clinical Microbiology and Infection (GCACMID), Infection Control Society of Taiwan (ICST), Taiwan Society of Microbiology (TSM), and Taiwan Society of Clinical Pathology and Laboratory Medicine (TSCPaLM). He has also served as a member of the Scientific Program Committee for several international congresses, including the International Congress of Antimicrobial Chemotherapy (ICC), American Society for Microbiology (ASM) Microbe, European Congress of Clinical Microbiology and Infectious Diseases (ESCMID), and other regional congresses on infectious diseases and clinical microbiology.
Currently, Professor Hsueh is the president of TSM and Society of Taiwan Long-Term Care Infection Prevention and Control (STLTCIPC). He is the Editor-in-Chief of the Journal of Microbiology, Immunology, and Infection (JMII, impact factor 4.399 in 2020), Section Editor of the International Journal Antimicrobial Agents (IJAA), funding editor of the Journal of Global Antimicrobial Resistance (JGAR), provides editorial input to several prestigious journals, and is a reviewer for more than 50 journals. His major research interests include clinical microbiology, epidemiology and mechanisms of antimicrobial resistance (bacteria, mycobacteria, and fungi), molecular epidemiology of emerging pathogens, and molecular diagnosis of infectious agents, infection control, and emerging viral infections. Professor Hsueh has authored more than 1,000 original research and review articles.
MARTIN KIERNAN
United Kingdom
Martin Kiernan (United Kingdom)
Martin Kiernan
MPH MClinRes RN
Martin Kiernan has worked in infection prevention and control for 32 years in a variety of settings. He is Reader in Epidemiology at the Richard Wells Research Centre at the University of West London, Conjoint Fellow at the University of Newcastle (New South Wales) and a Clinical Consultant to GAMA Healthcare.
He is a former Nurse Consultant and Deputy Director of Infection Prevention and Control at Southport and Ormskirk NHS Trust in North-West England. In 2020 and 2021 during the COVID pandemic he worked as an Infection Prevention lead at the London Nightingale Hospital constructed inside an exhibition centre at the request of the UK Government.
Martin was a member of the Department of Health (England) advisory committee on antimicrobial resistance, prescribing and healthcare-associated infection for ten years, is past president of the Infection Prevention Society (IPS) and was chair of the scientific program committee of the Healthcare Infection Society (HIS) international conferences in 2014, 2016 and 2018. Along with colleagues from Australia, he co-hosts a podcast series called ‘Infection Control Matters’ focusing on the latest research and other topical issues in infection prevention.
His research interests centre on environmental hygiene, healthcare-associated pneumonia and urinary catheter-associated infection. He has presented at many international conferences and has published over 60 papers and articles in peer-reviewed journals.
MO YIN
Singapore
Mo Yin (Singapore)
Dr Mo Yin is an infectious disease physician at National University Hospital, Singapore, and is the deputy director of the ADVANCE-ID network. Her research interest is in antimicrobial resistance and emerging infectious diseases. She is the lead investigator for the REGARD-VAP (Reducing Antibiotic Treatment Duration for Ventilator-Associated Pneumonia) trial and has conducted several multinational randomised trials.
PAUL A. MALPIEDI
United States of America
Paul A. Malpiedi (United States of America)
Paul Malpiedi is an epidemiologist in the International Infection Control Program at the US Centers for Disease Control and Prevention. He works with Ministries of Health and their partners to improve infection prevention and control programs and develop hospital-based surveillance systems for healthcare-associated infections and antimicrobial resistance in South and Southeast Asia, the Middle East, and West Africa.
PAUL ANANTHARAJAH TAMBYAH
Singapore
Paul Anantharajah Tambyah (Singapore)
Paul Anantharajah Tambyah completed his infectious diseases training at the University of Wisconsin under Dr Dennis Maki (one of the pioneers of critical care medicine!). Since returning to Singapore more than 20 years ago, he has been involved in a number of national and international committees including being founding head of the Division of ID, NUH, Assistant Dean (Education) at the Yong Loo Lin School of Medicine and past President of the Society of Infectious Diseases (Singapore). He is currently President of the Asia Pacific Society of Clinical Microbiology and Infection and President-elect of the International Society of Infectious Diseases. His main research interests are device associated infections and emerging infectious diseases.
SASHEELA AP SRI LA SRI PONNAMPALAVANAR
Malaysia
Sasheela AP Sri La Sri Ponnampalavanar (Malaysia)
Sasheela Ponnampalavanar is a Consultant Infectious Disease Physician at the University Malaya Medical Centre (UMMC) and Professor of Medicine at University Malaya, Malaysia. She is a Committee Member of The Malaysian National Antimicrobial Resistance Committee and is involved in the development of the national guidelines in infection prevention and antimicrobial stewardship. She was awarded the 2020/2021 Fulbright scholarship and was attached Hospital Epidemiology and Infection Control Department at the John Hopkins Hospital from Sept 2021 to Dec 2021. She is currently a committee member of the Malaysian Society of Infectious Diseases and Infection Control (MyICID) and the Malaysian Society of Infectious Disease and Chemotherapy (MSIDC). Her main interest is in hospital acquired infection, antimicrobial stewardship and multidrug resistant organism. Dr Sasheela is involved in several local and international research collaborations in these areas of interest.
SHARON SALMON
Philippines
Sharon Salmon (Philippines)
Dr Sharon Salmon is Technical Officer, Global Outbreak Alert and Response Network (GOARN) and Incident Manager for the Western Pacific Region Incident Management System Team (WPR IMST) – COVID-19 Lead for Partnership Coordination plus Lead for Infection Prevention & Control and Clinical Management. “Being involved with GOARN for so many years it is my dream job to not only represent GOARN at the regional level but also to represent the nursing profession for global health”.
Sharon has a long history with GOARN training as a faculty member since 2008 and conducted several GOARN outbreak missions including providing infection, prevention and control (IPC) technical assistance for the West Africa EVD Outbreak in Liberia three times during various stages of the outbreak.
Prior to joining WHO, Sharon was the Assistant Director of Nursing, Infection Prevention at the National University Hospital, Singapore and Associate Consultant, Ministry of Health Singapore. She has 20 years of IPC experience, including over five years in Vietnam working with various NGOs and WHO. She has extensive international consultative experience, providing technical advice for IPC national programmes, hospital assessments and development of national guidelines across several countries in Asia.
Sharon has successfully built a Partnership Coordination Team within the COVID-19 WPR IMST and facilitates engagement with partners through virtual meetings, to update on regional response efforts and plans. Since joining WHO she has developed strategies to engage partners and improve IPC practices across the region .
Nevertheless, the job has its challenges, she explained. “We strive to synthesize all the amazing response work within western pacific region and articulate this in a structured framework to the partners so that we have a strong coordinated response to the COVID-19 pandemic”.
Sharon is delighted that this year has been dedicated as the Year of the Nurse and Midwife. “Being involved in many outbreak response missions it is seldom that I encounter nurses in the field, and there is a need for nurses in outbreak response . I have spent most of my career advocating for nurses to break away from the stereotypical image of nursing at the bedside only and promote the massive work nurses and midwives can play in public health and especially during outbreak response”.
Alongside many of her nursing colleagues at WHO, she is acutely aware of the enormous pressure on dedicated nursing staff at this time. “During the past 9 years in Singapore I have worked alongside nursing leaders who have decades of experience. These nurses continue to mentor and advocate for patients and embrace innovation and constant changes in health delivery. These skilled nurses are the role models for future nurses and without these them health systems would not exist. The YONM is long awaited and the COVID-19 response has heightened the need for nursing professionals. We are a profession and need to be recognized as one”.
Sharon holds a Bachelor of Nursing, Master of Public Health from the University of Sydney and also a PhD from the University of NSW, Australia.
Listen to Sharon telling us more about her work with partners in the Western Pacific Region here.
SHAWN VASOO
Singapore
Shawn Vasoo (Singapore)
Dr Shawn Vasoo is Clinical Director and Senior Consultant at the National Centre for Infectious Diseases (NCID), Singapore. He graduated from the National University of Singapore in 2001, and completed his residency training in Internal Medicine and his fellowship in Infectious Diseases at Rush University Medical Center in Chicago and following that, a Clincal Microbiology Fellowship and Orthopaedic ID fellowship at the Mayo Clinic in Rochester, Minnesota. He also leads the Infectious Diseases Research Laboratory at NCID. He is active in undergraduate and postgraduate medical education and as Clinical Director oversees clinical and outbreak preparedness activities at NCID, which is a ~330 bed facility in Singapore purpose-built for outbreaks, and also chairs the COVID-19 therapeutic workgroup in Singapore. Besides COVID-19, he oversaw responses at NCID to several outbreak responses in recent years, including measles and monkeypox in 2019.
SHERRY CHUA
Singapore
Sherry Chua (Singapore)
Ms Chua Puay Hoon, Sherry is currently a Nurse Clinician working in Ambulatory Endoscopy Centre, Singapore General Hospital, Singapore.
• Has 39 years of nursing experience. Of which, she spent 27 years in Endoscopy Nursing.
• Graduated as Enrolled Nurse in 1981.
• Graduated as Registered nurse in 1984.
• Had an Advanced Diploma in Operating Theatre Nursing in 2002.
• Obtained Bachelor of Health Science (Nursing) from University of Sydney in 2005.
• Research Publication – Patient Satisfactory with colonoscopy in 2004
• Co-Author for Research study – Prospective Case-Control Study to Validate Hp One (GI Supply Check-Med Systems, Inc in the Diagnosis of Helicobacter Pylori Infection)
• Actively involved with Quality Improvement projects from 2004 till date.
• Actively involved in teaching and organising local and regional workshops since 2001 till date.
• Participated in design and planning of 4 endoscopy centres since 2005.
• Currently, involves with planning of new endoscopy centre at the New Elective Care Centre.
• Committee members of Nursing Chapter, Gastroenterology Society of Singapore GESS from 2003 till date.
• Chairperson of Nursing Chapter, Gastroenterology Society of Singapore GESS from 2011 to 2012.
• Awarded the MOH Nurses Merit Award on 7 July 2017.
• Ad-hoc teaching for Specialist Endoscopy Nursing Care in Nanyang Polytechnics, Singapore from 2017 to 2018.
SOMANI JYOTI
Singapore
Somani Jyoti (Singapore)
Dr. SOMANI (Jyoti)
Senior Consultant, Division of Infectious Diseases
National University Hospital
Chair, NUH Infection Control Committee
Director, NUH Epidemiology
Clinical Director, NUH Antimicrobial Stewardship Team
Dr. Somani is from the U.S. and has been living in Singapore since November 2014. She graduated from the University of Cincinnati medical school in 1991 and attended the University of Chicago Hospitals for her Internal Medicine Residency and the first year of her Infectious Disease Fellowship. She completed her ID fellowship at Emory University. Dr. Somani was in the US Indian Health Service (1998-2000), then became an Assistant Professor of Infectious Disease at Emory University (2000-2004). From 2004-2008, she worked on a HIV and Leadership Training Program for doctors in Chennai, India. She also spent time in private practice in Atlanta (2008-2012) and subsequently the Australian Embassy clinic and Siloam Hospitals in Jakarta (2012-2014). Dr. Somani then joined the General Medicine Department at Khoo Teck Puat Hospital, Singapore in 2014. In late 2018, she moved to NUHS as a Senior Consultant for the Division of Infectious Diseases and as the Clinical Director of the ASP program. She is currently also the Director of the NUH Hospital Epidemiology Unit and Chair of the Infection Control Committee. She has been actively involved in the COVID response for NUH, and remains passionate about the rational use of antibiotics. Her clinical interests include transplant related infectious diseases.
SURINDER KAUR M S PADA
Singapore
Surinder Kaur M S Pada (Singapore)
Dr Surinder Pada is the Head of the Division of Infectious Diseases in JurongHealth Campus. She practises as a Senior Consultant in Ng Teng Fong General Hospital. She is also the Chairperson of Infection Control in JurongHealth Campus and a Visiting Consultant Physician for Infectious Diseases at the National University Hospital.
Dr Pada graduated from the Faculty of Medicine at the University of New South Wales, Sydney. She is a fellow of the Australasian College of Physicians (FRACP) and completed a six-month Health Manpower Development Plan with the Johns Hopkins Hospital in Baltimore as an Infection Control Fellow. Her main research interests are in multi-drug resistant organisms and emerging infectious diseases.
SUSAN HUANG
United States of America
Susan Huang (United States of America)
Susan Huang, MD MPH is Professor of Medicine in the Division of Infectious Diseases and Health Policy Research Institute at the University of California Irvine School of Medicine, and the Medical Director of Epidemiology and Infection Prevention at UC Irvine Health. For over 15 years, Dr. Huang has been studying healthcare-associated infections with a focus on multidrug-resistant organisms (MDROs). Her clinical epidemiologic research seeks to identify the burden and risk factors for acquisition and disease, and preventative strategies for containment. Dr. Huang has led several large randomized clinical trials to prevent MRSA disease and other healthcare-associated infections. She also studies the regional prevention of MDROs in hospitals and nursing homes through epidemiologic studies as well as simulation models. Dr. Huang has over 150 publications and has served as a member of U.S. HICPAC, the U.S. CDC Antibiotic Resistance Working Group, and the IDSA Antibiotic Resistance Committee.
STEPHAN HARBARTH
Switzerland
Stephan Harbarth (Switzerland)
Stephan Harbarth earned in 1993 his medical degree from Ludwig-Maximilians-University in Munich, Germany, and completed his residency in internal medicine and tropical medicine at Munich University Hospitals. After serving as a clinical fellow in the Infectious Diseases Division in the Department of Internal Medicine at Geneva University Hospitals, Dr Harbarth completed his master’s degree in epidemiology at Harvard University in Boston. He is board certified in infectious diseases and was appointed full professor at the University of Geneva in 2018. Dr Harbarth’s work has garnered several awards. His group is currently conducting several clinical and epidemiological studies to evaluate key questions related to the control of the acquisition, transmission and infection by multidrug-resistant microorganisms and related clinical and health-economic burden. He participates in several ongoing large-scale EU-funded studies (R-GNOSIS, AIDA, COMBACTE) and coordinated the DRIVE-AB project to address this public health threat.
TAN BAN HOCK
Singapore
Tan Ban Hock (Singapore)
Dr Tan graduated from the National University of Singapore and obtained his MRCP (Edinburgh) in 1995. He went on to train in infectious diseases in Singapore and at the Massachusetts General Hospital in Boston, Massachusetts, USA. He has been Head of Infectious Diseases and of Internal Medicine at SGH. He is currently Infectious Diseases Lead with SingHealth Transplant, and is President of the Transplant Infections Disease Section of The Transplantation Society. He served for 9 years as co-chair of the Asia Fungal Working Group.
Dr Tan has a keen interest in the study of infections in immunocompromised hosts, and is particularly interested in infections in transplant recipients and febrile neutropenic patients
THOMAS RILEY
Australia
Thomas Riley (Australia)
Professor Thomas V Riley
BAppSc Curtin, MAppEpid ANU, PhD UWA, FASM, FRCPath, FAAM, FSHEA, FFSc(RCPA)
School of Biomedical Sciences, The University of Western Australia
Department of Microbiology, PathWest Laboratory Medicine (WA)
School of Medical & Health Sciences, Edith Cowan University
School of Veterinary and Life Sciences, Murdoch University
Tom Riley divides his time in Perth, Western Australia, between PathWest Laboratory Medicine, WA’s public sector pathology service provider where he is a Senior Clinical Scientist, Edith Cowan University where he is a Professorial Research Fellow, Murdoch University where he is Professor of Public Health and The University of Western Australia. He has had a long-standing interest in healthcare-related infections, particularly the diagnosis, pathogenesis and epidemiology of Clostridiodes (Clostridium) difficile infection. He is a Fellow of the Royal College of Pathologists, the Australian Society for Microbiology, the American Academy of Microbiology, the Society for Healthcare Epidemiology of America and the Faculty of Science of the Royal College of Pathologists of Australasia and has published >400 book chapters and refereed journal articles, including >200 on C. difficile.
TRISH PERL
United States of America
Trish Perl (United States of America)
Trish M. Perl, MD, MSc, is the H. Ben and Isabelle T. Decherd Chair in Internal Medicine (Infectious Diseases and Geographic Medicine) at UT Southwestern Medical Center in Dallas TX. Dr. Perl received her Medical Degree from the University of North Carolina (Chapel Hill) and a Master of Science from McGill University in Montreal, Canada.
She trained in Internal Medicine at the Royal Victoria Hospital and in Infectious Diseases and Clinical Epidemiology at the University of Iowa. She rose through the ranks to Professor of Medicine at Johns Hopkins University School of Medicine and Epidemiology at the Bloomberg School of Public Health and is recognized globally for her innovation and research in healthcare associated infections, antimicrobial resistance, and their transmission and prevention. As the Hospital Epidemiologist at Johns Hopkins Hospital and Health System Epidemiologist, she developed extensive practical and research experience. Internationally, she has helped with outbreak management and mitigation including caused by SARS, MERS CoV, Ebola and consults on guideline development and strategies to prevent emerging threats in healthcare. She is actively involved in monitoring the COVID-19 pandemic and supporting the national and local response.
VERNON LEE
Singapore
Vernon Lee (Singapore)
Vernon Lee
MBBS, PhD, FAMS, FAMM, MPH, MBA
Prof Vernon Lee is a preventive medicine physician and Senior Director of the Communicable Diseases Division at the Ministry of Health, Singapore. He is also adjunct Professor at the Saw Swee Hock School of Public Health, National University of Singapore, and sits on the Council of the Academy of Medicine, Singapore.
His areas of expertise include infectious diseases epidemiology, pandemic preparedness and response, and evidence-based health policy.
He has previously worked in the WHO Office in Indonesia and WHO headquarters in Geneva, and continues to contribute to international working groups and advisory panels on infectious diseases.
Prof Lee graduated from medical school at the National University of Singapore. He also holds a PhD in epidemiology from the Australian National University, and the Master in Public Health and Master of Business Administration degrees from the Johns Hopkins University, USA.
VIJI VIJAYAN
Singapore
Viji Vijayan (Singapore)
Dr Viji Vijayan
MBBS, MSc, MD, RBP, MSc Associate Professor and Associate Dean
Associate Professor Viji Vijayan’s career began in a biomedical research laboratory, where she worked for about 10 years after which she switched to Research Operations and Laboratory Safety. She now holds the position of Associate Dean in the Duke-NUS Medical School. In this role, she oversees Safety, Health and Emergency Management; Procurement; and Research Operations. Safety science is a passion that she has nurtured in the last three decades, especially the integration of safety into everyday work life because her motto is that “Safety is Simply the Way you Work”.
She serves in various organizations relating to the practice of biorisk. She was the President of the Biorisk Association of Singapore from 2014 to 2017 and Vice President of Asia Pacific Biosafety Association from 2019-021. She is currently a member of the Board of Directors of the International Federation of Biosafety Associations. She also consults in the field of biorisk for various organizations like the European Union CBRN Centers of Excellence, World Health Organization and Biosecurity Engagement Program through their partner agencies and Global Affairs Canada though their projects in Southeast Asia.
She has completed the WSQ Advanced Certificate in Training and Assessment (ACTA) certification which specializes in adult training methodologies. She has a Master’s degree in Human Factors and Systems Safety from Lund university in Sweden. Her extensive expertise in the field of biorisk and knowledge she has gained about safety in other industries like aviation, rail transportation, etc through the Master’s Program, gives her a unique set of skills and abilities that enables her to develop and implement biorisk management systems with a distinctive approach. She is passionate about training and tailors it precisely to the audience from different regions with different needs and expectations.
WILLIAM R. JARVIS
United States of America
William R. Jarvis (United States of America)
William R. Jarvis, M.D. is board-certified in pediatrics and board-eligible in pediatric infectious diseases. From 1980-2003, Dr. Jarvis worked at the Centers for Disease Control and Prevention (CDC), in a number of leadership positions including Acting Director, Hospital Infections Program (HIP); Assistant Director for Program Development, Division of Healthcare Quality Promotion (DHQP); and Director, Office of Extramural Research, Office of the Director, National Center for Infectious Diseases. For 17 years while at the CDC, Dr. Jarvis was responsible for the supervision of outbreaks and epidemiologic studies in healthcare settings and for the development of guidelines for the prevention of healthcare-associated infections (HAIs). He is the past president of the Society for Healthcare Epidemiology of America, Past President of the Association for Professionals in Infection Control and Epidemiology (APIC) Research Foundation, and past editor of Infection Control and Healthcare Epidemiology. He is the Chairman of the Food and Drug Administration’s General Hospital and Personal Use Committee. In July 2003, Dr. Jarvis established Jason and Jarvis Associates, LLC, a consulting company in epidemiology, infectious diseases, and HAI prevention and control. Dr. Jarvis has published >400 peer-reviewed publications, edited six books, and has received numerous awards, including the CDC Lifetime Scientific Achievement Award and the CDC Lifetime Achievement Award in Epidemiology.
YEE-CHUN CHEN
Taiwan
Yee-Chun Chen (Taiwan)
Prof Chen is one of the nation’s leaders in infection control and medical mycology in Taiwan. Prof Chen’s research focus includes clinical and molecular epidemiology of invasive fungal diseases, surveillance of healthcare-associated infection and medical informatics, diagnostic and therapeutic strategies for invasive fungal infections, and One Health Perspective of azole-resistant Aspergillus and Candida infection. She has authored or coauthored more than 330 peer-reviewed journal articles such as Emerging Infection Diseases, Clinical Infectious Diseases, Clinical Microbiology and Infection, Journal of Antimicrobial Chemotherapy, J Med Internet Res, PLoS One, Journal of Clinical Microbiology, Medical Mycology, Journal of the Formosan Medical Association and Journal of Microbiology, Infection and Immunology. Her researcher’s profile is available at https://scholars.lib.ntu.edu.tw/cris/rp/rp06583/otherinfo.html.
Dr. Chen has received several awards for combating COVID-19 in 2020, such as the Health and Welfare Profession Medal Award from Ministry of Health and Welfare, Taiwan. Other achievement awards included Academic Awards from The Infectious Diseases Society of Taiwan and Formosa Medical Association, Teaching Award from NTUH and NTU; Epidemic Prevention and Control Award from CDC, Taiwan; and, on behalf of NTUH, National Healthcare Quality Award from the Joint Commission of Taiwan (Bronze Award of Smart Healthcare Category, Medical Informatics), Quality Improvement Awards from CDC and Taipei City Government; Asia Pacific Hand Hygiene Excellent Award from Asia-Pacific Society of Infection Control and WHO Collaborating Centre on Patient Safety, Switzerland.
ZONG ZHI YONG
China
Dr Zong Zhi Yong (China)
Dr. Zhiyong Zong
Professor and consultant physician, Center of Infectious Diseases,
Director, Infection Control Department,
Director, Center for Pathogen Research,
West China Hospital, Sichuan University, Chengdu, China.
Dr. Zong is a senior physician-scientist for infectious diseases and is in charge of the infection control program in West China Hospital, Sichuan University, Chengdu, China. He was the International Ambassador of the Society for Healthcare Epidemiology of America in 2011 and is an awardee of the Newton Advanced Fellowship, Royal Society, UK. His expertise is in the management of multi-drug resistant organisms (MDRO) infections in critically ill or immunocompromised patients. His main research interests are the epidemiology and mechanisms of antimicrobial resistance in the Enterobacteriaceae and the prevention and control of MDRO. He has authored >180 peer-reviewed papers in Science Citation Index-indexed journals. He is an editor of Microbial Genomics and European Journal of Clinical Microbiology and Infectious diseases and a member of the Editor Board of Antimicrobial Agents and Chemotherapy.